Results 11 to 20 of about 1,656 (194)

Neuroimaging and clinicopathological differences between tumefactive demyelinating lesions and sentinel lesions of primary central nervous system lymphoma [PDF]

Frontiers in Immunology, 2022
ObjectiveIt is still a challenge to distinguish sentinel lesions of primary central nervous system lymphoma (PCNSL) from atypical tumefactive demyelinating lesions (TDLs) in clinical practice.
Chenjing Sun, Jinming Han, Ye Lin, Xiaokun Qi, Changqing Li, Jianguo Liu, Feng Qiu   +6 more
doaj   +4 more sources

Identifying Tumefactive Demyelination on Synthetic MRI Myelin Maps [PDF]

Case Reports in Radiology
Tumefactive demyelinating lesions and brain neoplasms often present as a diagnostic challenge due to overlapping radiographic features among conventional imaging modalities ultimately resulting in uncertainty if a biopsy is warranted to establish a ...
Brandon Simons, Rebecca Li, Tushar Chandra, Laura Hayes   +3 more
doaj   +3 more sources

Tumefactive Demyelinating Lesion Induced by Infliximab in a Patient With Rheumatoid Arthritis: A Case Report [PDF]

Clinical Case Reports
Tumor Necrosis Factor‐alpha (TNF‐α) inhibitors have been successfully used to treat rheumatoid arthritis (RA), psoriatic and ankylosing arthritis, and inflammatory bowel disease.
Shahla Mohammed Saeed Rasul, Zana Abdulrahman Mohammed, Aran Asaad Adiban, Yahya Jawad Kadhm   +3 more
doaj   +3 more sources

Tumefactive demyelination: Clinical outcomes, lesion evolution and treatments [PDF]

Multiple Sclerosis Journal - Experimental, Translational and Clinical, 2019
Objective Large demyelinating lesions with possible mass effect (tumefactive multiple sclerosis or tumefactive demyelination) can be mistaken for tumour-like space-occupying lesions suggesting a malignant outcome.
Staley A Brod, J William Lindsey, Flavia Nelson   +2 more
doaj   +3 more sources

Tumefactive demyelinating lesions: a case report and literature review [PDF]

BMC Neurology
Tumefactive multiple sclerosis (TMS) is a rare and diagnostically challenging variant of demyelinating disease that frequently mimics neoplastic, infectious, or vascular brain lesions.
Raneem Jaki, Zyad Al-Frejat, Ziad Bitar
doaj   +2 more sources

Tumefactive demyelinating lesions: a retrospective cohort study in Thailand [PDF]

Scientific Reports
Tumefactive demyelinating lesions (TDL), characterized by large (≥ 2 cm) demyelinating lesions mimicking tumors, are a rare manifestation of the central nervous system inflammatory demyelinating diseases (CNS-IDD).
Tatchaporn Ongphichetmetha, Saharat Aungsumart, Sasitorn Siritho, Metha Apiwattanakul, Jantima Tanboon, Natthapon Rattanathamsakul, Naraporn Prayoonwiwat, Jiraporn Jitprapaikulsan   +7 more
doaj   +2 more sources

Subgroup analysis of tumefactive demyelinating lesions: clinical, imaging features and outcomes [PDF]

BMJ Neurology Open
Background Tumefactive demyelinating lesions (TDLs) are rare, large demyelinating lesions of the central nervous system that can mimic brain tumours in radiological appearance. They have been observed across multiple demyelinating diseases.
Zheng Liu, Dawei Li, Yuqi Tang, Zhandong Qiu, Yingyue Ding, Huiqing Dong   +5 more
doaj   +2 more sources

Tumefactive multiple sclerosis requiring emergent biopsy and histological investigation to confirm the diagnosis: a case report [PDF]

Journal of Medical Case Reports, 2012
Introduction Tumefactive multiple sclerosis is a demyelinating disease that demonstrates tumor-like features on magnetic resonance imaging. Although diagnostic challenges without biopsy have been tried by employing radiological studies and cerebrospinal ...
Yamada So, Yamada Shoko, Nakaguchi Hiroshi, Murakami Mineko, Hoya Katsumi, Matsuno Akira, Yamazaki Kazuto, Ishida Yasuo   +7 more
doaj   +5 more sources

Tumefactive demyelinating lesions: A Clinicopathological correlative study

Indian Journal of Pathology and Microbiology, 2012
Tumefactive demyelinating (TDL) lesions are focal zones of demyelination in the central nervous system and they often mimic the neuroimaging features of an intraxial neoplasm.
R Neelima, K Krishnakumar, M D Nair, C Kesavadas, Divyata Rajendra Hingwala, V V Radhakrishnan, Sruthi S Nair   +6 more
doaj   +3 more sources

Non‐Syndromic Tumefactive Demyelinating Lesions in the Pediatric Population: Four Case Reports and Review of the Literature

Annals of the Child Neurology Society
Introduction Tumefactive demyelinating lesions (TDLs) are large lesions (> 2 cm) seen in demyelinating syndromes such as multiple sclerosis, myelin oligodendrocyte glycoprotein antibody‐associated disorder, and neuromyelitis optica spectrum disorder ...
Elizabeth C. Ballinger, Hannah F. Todd, Jonathan M. Yarimi, Timothy E. Lotze, Nikita M. Shukla, Kristen S. Fisher, Alexander J. Sandweiss   +6 more
doaj   +2 more sources